Tag Archives: metastatic prostate cancer

FDA Approves the First Immunotherapy, Provenge, for Metastatic Prostate Cancer

For men with advanced metastatic prostate cancer that did not respond to hormone therapy, there is a new hope for improved survival.  FDA has approved an immunotherapy sipuleucel-T (Provenge, Dendreon), for the treatment of asymptomatic or minimally symptomatic metastatic, castration-resistant … Continue reading

Posted in Cancer, Prostate cancer | Tagged , , , , , | Comments Off on FDA Approves the First Immunotherapy, Provenge, for Metastatic Prostate Cancer